CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 74 enrolled
Drug / intervention
Chloroprocaine 3% eye gel +1 moredrug
Likely dose
Chloroprocaine 3% eye gel or Oxybuprocaine 0.4% eye drops (exact dosing and dosing schedule not specified in provided text)AI-extracted
Key inclusion· 4
  • Age from birth (≥1 day of life) through 17 years, not expected to turn 18 during study
  • Scheduled to undergo a routine clinical procedure requiring local ocular surface anesthesia (applanation tonometry, gonioscopy, UBM, ocular ultrasonography, retinal examination, etc.)
  • For females of childbearing potential (postmenarchal): negative pregnancy test, not lactating, and agreement to abstain from intercourse or use valid contraceptive until study completion
  • Signed written informed consent from both parents/legal representatives and written assent from adolescents aged 12-17 years (and whenever possible from children aged 6-11 years)
Key exclusion· 9
  • Previous ocular surgery less than 6 months before screening
  • Eye movement disorder (nystagmus)
  • History of herpetic keratitis
  • Corneal disease (epithelial, stromal, or endothelial; residual or evolutionary), including corneal ulceration, damage, or superficial punctate keratitis

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05926258
NCT05926258Phase 3Completed

A Prospective, Observer-blind, Randomized Clinical Trial to Investigate and Compare the Clinical Efficacy of Chloroprocaine 3% Gel and Oxybuprocaine 0.4% Eye Drops Anesthesia for Clinical Practice in Pediatric Population

Sintetica SA·interventional·Posted Jul 3, 2023·Updated Mar 9, 2026

In Brief

A Phase 3 clinical trial evaluating Chloroprocaine 3% eye gel and Oxybuprocaine Hydrochloride 4 Mg/mL Eye Drops for Local Anesthetic. Completed, enrolled 74 participants across 3 sites.

Detailed Summary

The goal of this clinical trial is to assess the efficacy and safety of Chloroprocaine 3% eye gel compared to Oxybuprocaine 0,4% eye drops when used for inducing ocular surface anesthesia in pediatric patients. 74 Participants (male and female, aged 0-17 yrs) will be 1:1 randomized for receiving either the test drug (Chloroprocaine) or the reference drug (Oxybuprocaine) before undergoing to ocular exam who needs ocular surface anesthesia. The successful surface anesthesia will be evaluated 5 minutes after receiving 2 drops (1 minute apart) of either test or reference drug by an eye spear sponge

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesItaly
CollaboratorsCross Research S.A.

Timeline

Phase 3CompletedFinished
202420252026
First PostedJul 3, 2023
Enrollment StartMay 23, 2024
Primary CompletionMar 13, 2025
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 3.0 years ago

Interventions

Chloroprocaine 3% eye geldrug

ocular surface anesthesia

Oxybuprocaine Hydrochloride 4 Mg/mL Eye Dropsdrug

ocular surface anesthesia